谷氨酰胺酶
小胶质细胞
神经认知
谷氨酸受体
围手术期
医学
药理学
调解人
谷氨酰胺
神经科学
神经保护
认知功能衰退
生物信息学
败血症
临床意义
病态的
生物
炎症
生物标志物
认知
癌症研究
治疗方法
机制(生物学)
脂质信号
神经递质
认知障碍
下调和上调
免疫学
内科学
作者
Yiyan Sun,Yun Li,Fengping Zhang,Zhongli Wan,Xiaoming Zhang,Ping Xu,Yi Wang,Congcong Li,Yuanyuan Zuo,Jiehui Liu,Ying Wu,Changqi Chen,Xuanran Feng,Xiaohuan Xia,Jialin Zheng,Jianhui Liu
标识
DOI:10.1038/s41418-026-01833-3
摘要
Abstract Perioperative neurocognitive disorders (PND) are common neurological complications in elderly surgical patients, for which effective mechanism-based therapies remain lacking. This study identifies ferroptosis, an iron-dependent lipid peroxidation-driven cell death, as a key pathological process in PND, and pharmacological inhibition of ferroptosis with ferrostatin-1 significantly ameliorated cognitive deficits in a surgery and anesthesia-induced mouse model of PND. Moreover, accumulation of glutamate has been observed in the brains of PND mice, which competitively inhibits the neuronal cystine/glutamate antiporter system Xc - (via SLC7A11) to trigger glutathione depletion and ferroptotic cell death. Excessive glutamate production and release are driven by hyperexpression of glutamate-producing enzyme glutaminase 1 (GLS1) in activated microglia via STAT1-dependent transcriptional activation. Pharmacological inhibition of GLS1 with the selective inhibitors CB839 and BPTES suppressed ferroptosis, preserved synaptic plasticity, and improved cognitive performance in PND mice, indicating GLS1 as a potential therapeutic target of PND. Notably, elevated plasma GLS1 levels in PND patients correlated negatively with cognitive test scores ( R 2 = 0.479, p < 0.001) and exhibited moderate diagnostic value across two independent cohorts (AUCs = 0.77 and 0.84), underscoring its clinical relevance as a potential biomarker. Collectively, our findings establish microglial GLS1 as a critical mediator of ferroptosis in PND and highlight its dual promise as a therapeutic target and diagnostic indicator.
科研通智能强力驱动
Strongly Powered by AbleSci AI